These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3104958)

  • 21. Involvement of dopamine in circling responses to muscimol depends on intranigral site of injection.
    Kilpatrick IC; Starr MS
    Eur J Pharmacol; 1981 Feb; 69(4):407-19. PubMed ID: 6265225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serotonergic innervation of the rat caudate following a neonatal 6-hydroxydopamine lesion: an anatomical, biochemical and pharmacological study.
    Towle AC; Criswell HE; Maynard EH; Lauder JM; Joh TH; Mueller RA; Breese GR
    Pharmacol Biochem Behav; 1989 Oct; 34(2):367-74. PubMed ID: 2576138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GABAergic and glycinergic mechanisms within the substantia nigra: pharmacological specificity of dopamine-independent contralateral turning behavior and interactions with other neurotransmitters.
    Arnt J; Scheel-Krüger J
    Psychopharmacology (Berl); 1979 Apr; 62(3):267-77. PubMed ID: 37544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Substantia nigra glutamate antagonists produce contralateral turning and basal ganglia Fos expression: interactions with D1 and D2 dopamine receptor agonists.
    McPherson RJ; Marshall JF
    Synapse; 2000 Jun; 36(3):194-204. PubMed ID: 10819899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine receptor 'supersensitivity' occurring without receptor up-regulation.
    Mileson BE; Lewis MH; Mailman RB
    Brain Res; 1991 Oct; 561(1):1-10. PubMed ID: 1686741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopaminergic grafts in the striatum reduce D1 but not D2 receptor-mediated rotation in 6-OHDA-lesioned rats.
    Robertson GS; Fine A; Robertson HA
    Brain Res; 1991 Jan; 539(2):304-11. PubMed ID: 1675908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GABA receptor agonist promotes reformation of the striatonigral pathway by transplant derived from fetal striatal primordia in the lesioned striatum.
    Goto S; Yamada K; Yoshikawa M; Okamura A; Ushio Y
    Exp Neurol; 1997 Oct; 147(2):503-9. PubMed ID: 9344574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A physiological role for dopamine as modulator of GABA effects in substantia nigra: supersensitivity in 6-hydroxydopamine-lesioned rats.
    Waszczak BL; Walters JR
    Eur J Pharmacol; 1984 Oct; 105(3-4):369-73. PubMed ID: 6439567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-specific supersensitivity of striatal dopamine receptors after 6-hydroxydopamine lesion of the nigrostriatal pathway.
    Costall B; Naylor RJ; Pycock C
    Eur J Pharmacol; 1976 Feb; 35(2):276-83. PubMed ID: 942921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An investigation of the role played by the superior colliculus and ventromedial thalamus in self-injurious behavior produced by intranigral microinjection of muscimol.
    Baumeister AA; Frye GD; Moore LL
    Pharmacol Biochem Behav; 1987 Jan; 26(1):187-9. PubMed ID: 3562491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Behavioural recovery following transplantation of substantia nigra in rats subjected to 6-OHDA lesions of the nigrostriatal pathway. II. Bilateral lesions.
    Dunnett SB; Björklund A; Stenevi U; Iversen SD
    Brain Res; 1981 Dec; 229(2):457-70. PubMed ID: 6796197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Self-injurious behavior in rats produced by intranigral microinjection of GABA agonists.
    Baumeister AA; Frye GD
    Pharmacol Biochem Behav; 1984 Jul; 21(1):89-95. PubMed ID: 6540454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neonatal 6-OHDA lesions differentially affect striatal D1 and D2 receptors.
    Neal BS; Joyce JN
    Synapse; 1992 May; 11(1):35-46. PubMed ID: 1351321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the role of antinociception in self-injurious behavior following intranigral injection of muscimol.
    Frye GD; Baumeister AA; Crotty K; Newman KD; Kotrla KJ
    Neuropharmacology; 1986 Jul; 25(7):717-26. PubMed ID: 2944027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Responses of substantia nigra pars reticulata neurons to GABA and SKF 38393 in 6-hydroxydopamine-lesioned rats are differentially affected by continuous and intermittent levodopa administration.
    Weick BG; Engber TM; Susel Z; Chase TN; Walters JR
    Brain Res; 1990 Jul; 523(1):16-22. PubMed ID: 2119854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unilateral striatal dopamine denervation: reduced motor inhibitory effects of dopamine antagonists revealed in models of asymmetric and circling behaviour.
    Costall B; Kelly ME; Naylor RJ
    Naunyn Schmiedebergs Arch Pharmacol; 1984 May; 326(1):29-35. PubMed ID: 6433208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacologic evaluation of SCH-39166, A-69024, NO-0756, and SCH-23390 in neonatal-6-OHDA-lesioned rats. Further evidence that self-mutilatory behavior induced by L-dopa is related to D1 dopamine receptors.
    Criswell HE; Mueller RA; Breese GR
    Neuropsychopharmacology; 1992 Sep; 7(2):95-103. PubMed ID: 1418306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for involvement of brain dopamine and other mechanisms in the behavioral action of the N-methyl-D-aspartic acid antagonist MK-801 in control and 6-hydroxydopamine-lesioned rats.
    Criswell HE; Johnson KB; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1993 May; 265(2):1001-10. PubMed ID: 8098756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in substantia nigra pars reticulata activity following lesions of the substantia nigra pars compacta.
    Sanderson P; Mavoungou R; Albe-Fessard D
    Neurosci Lett; 1986 Jun; 67(1):25-30. PubMed ID: 3014391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clozapine antagonism of D-1 and D-2 dopamine receptor-mediated behaviors.
    Criswell HE; Mueller RA; Breese GA
    Eur J Pharmacol; 1989 Jan; 159(2):141-7. PubMed ID: 2495973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.